Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

How useful are biomarkers for the prediction of short-term relapse in patients with Crohn's disease?

Nature Clinical Practice Gastroenterology & Hepatology volume 4, pages 72–73 (2007)Cite this article

boxed-textConsigny Y et al. (2006) A simple biological score for predicting low risk of short-term relapse in Crohn's disease. Inflamm Bowel Dis 12: 551–557

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Andre C et al. (1981) Assessment of appropriate laboratory measurements to supplement the Crohn's disease activity index. Gut 22: 571–574

    Article  CAS  Google Scholar 

  2. Cellier C et al. (1994) Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. Gut 35: 231–235

    Article  CAS  Google Scholar 

  3. Brignola C et al. (1986) A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 91: 1490–1494

    Article  CAS  Google Scholar 

  4. Boirivant M et al. (1988) The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. J Clin Gastroenterol 10: 401–405

    Article  CAS  Google Scholar 

  5. Florin et al. (2006) Clinically active Crohn's disease in the presence of a low C-reactive protein. Scand J Gastroenterol 41: 306–311

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. G Radford-Smith is the Head of the IBD Unit in the Department of Gastroenterology, Royal Brisbane and Women's Hospital, and the Director of the IBD Research Unit, Clinical Research Centre, Queensland Institute of Medical Research, Brisbane, Australia.,

    Graham Radford-Smith

  2. P O'Rourke is a Senior Biostatistician in the Biostatistics Division, Population Health Unit, Queensland Institute of Medical Research, Brisbane, Australia.,

    Peter O'Rourke

Authors
  1. Graham Radford-Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter O'Rourke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Graham Radford-Smith.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Radford-Smith, G., O'Rourke, P. How useful are biomarkers for the prediction of short-term relapse in patients with Crohn's disease?. Nat Rev Gastroenterol Hepatol 4, 72–73 (2007). https://doi.org/10.1038/ncpgasthep0716

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0716

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing